Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis

Detalles Bibliográficos
Autores principales: Lioger, Bertrand, Ferreira-Maldent, Nicole, Cottier, Jean Philippe, Debiais, Séverine, Gyan, Emmanuel, Maillot, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Clinical/Scientific Notes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949984/
https://www.ncbi.nlm.nih.gov/pubmed/27458597
http://dx.doi.org/10.1212/NXI.0000000000000253
_version_ 1782443504518037504
author Lioger, Bertrand
Ferreira-Maldent, Nicole
Cottier, Jean Philippe
Debiais, Séverine
Gyan, Emmanuel
Maillot, François
author_facet Lioger, Bertrand
Ferreira-Maldent, Nicole
Cottier, Jean Philippe
Debiais, Séverine
Gyan, Emmanuel
Maillot, François
author_sort Lioger, Bertrand
collection PubMed
description
format Online
Article
Text
id pubmed-4949984
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-49499842016-07-25 Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis Lioger, Bertrand Ferreira-Maldent, Nicole Cottier, Jean Philippe Debiais, Séverine Gyan, Emmanuel Maillot, François Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2016-07-08 /pmc/articles/PMC4949984/ /pubmed/27458597 http://dx.doi.org/10.1212/NXI.0000000000000253 Text en © 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Clinical/Scientific Notes
Lioger, Bertrand
Ferreira-Maldent, Nicole
Cottier, Jean Philippe
Debiais, Séverine
Gyan, Emmanuel
Maillot, François
Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
title Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
title_full Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
title_fullStr Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
title_full_unstemmed Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
title_short Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
title_sort rituximab for sjögren syndrome–associated type ii mixed cryoglobulinemic cerebral vasculitis
topic Clinical/Scientific Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949984/
https://www.ncbi.nlm.nih.gov/pubmed/27458597
http://dx.doi.org/10.1212/NXI.0000000000000253
work_keys_str_mv AT liogerbertrand rituximabforsjogrensyndromeassociatedtypeiimixedcryoglobulinemiccerebralvasculitis
AT ferreiramaldentnicole rituximabforsjogrensyndromeassociatedtypeiimixedcryoglobulinemiccerebralvasculitis
AT cottierjeanphilippe rituximabforsjogrensyndromeassociatedtypeiimixedcryoglobulinemiccerebralvasculitis
AT debiaisseverine rituximabforsjogrensyndromeassociatedtypeiimixedcryoglobulinemiccerebralvasculitis
AT gyanemmanuel rituximabforsjogrensyndromeassociatedtypeiimixedcryoglobulinemiccerebralvasculitis
AT maillotfrancois rituximabforsjogrensyndromeassociatedtypeiimixedcryoglobulinemiccerebralvasculitis

Ejemplares similares